Skip to main content
. Author manuscript; available in PMC: 2015 Oct 1.
Published in final edited form as: Mol Aspects Med. 2013 Oct 19;0:33–49. doi: 10.1016/j.mam.2013.10.003

Figure 2. MSC phenotypes and inferred roles of putative markers.

Figure 2

Clockwise from top left: Chemoresistance and tumorigenesis, metastasis, stem cell maintenance, vasculogenic mimicry, tumor microenvironment interactions, chromatin modifications/epigenetics, immunomodulation, and passive or active markers.